STOCK TITAN

Regency Centers (REG) director adds 1,952 shares through equity award vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Regency Centers director C. Ronald Blankenship reported routine equity compensation vesting. On May 11, 2026, he acquired 1,952 shares of Regency Centers common stock through the vesting and settlement of restricted stock and related dividend equivalent rights under the company’s Omnibus Incentive Plan. These transactions reflect compensation-related exercises, not open‑market purchases or sales, and left him holding 114,679 common shares directly.

Positive

  • None.

Negative

  • None.
Insider BLANKENSHIP C RONALD
Role null
Type Security Shares Price Value
Exercise Restricted Stock 1,875 $0.00 --
Exercise Dividend Equivalent Rights 77 $0.00 --
Exercise Common Stock 1,875 $0.00 --
Exercise Common Stock 77 $0.00 --
Holdings After Transaction: Restricted Stock — 0 shares (Direct, null); Dividend Equivalent Rights — 0 shares (Direct, null); Common Stock — 114,679 shares (Direct, null)
Footnotes (1)
  1. Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan. Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock.
Restricted stock vested 1,875 shares Restricted Stock converted to common on May 11, 2026
Dividend equivalent rights settled 77 shares Dividend Equivalent Rights converted to common on May 11, 2026
Total shares acquired via vesting 1,952 shares Exercise or conversion of derivative securities (code M)
Common shares owned after transactions 114,679 shares Direct ownership following May 11, 2026 transactions
Derivative exercises 2 transactions Exercise or conversion of derivative securities on May 11, 2026
Restricted Stock financial
"Restricted Stock grant pursuant to Regency's Omnibus Incentive Plan."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Dividend Equivalent Rights financial
"Settlement of dividend equivalent rights in connection with vesting of restrictive stock."
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
Omnibus Incentive Plan financial
"Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan."
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Exercise or conversion of derivative security regulatory
"transaction_code_description: Exercise or conversion of derivative security"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BLANKENSHIP C RONALD

(Last)(First)(Middle)
5004 GREEN TREE

(Street)
HOUSTON FLORIDA 77056

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026M1,875A(1)114,679D
Common Stock05/11/2026M77A(2)114,756D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock$005/11/2026M1,875 (1) (1)Common Stock1,875$00D
Dividend Equivalent Rights$005/11/2026M77 (2) (2)Common Stock77$00D
Explanation of Responses:
1. Vesting of restricted stock grant pursuant to Regency's Omnibus Incentive Plan.
2. Settlement of dividend equivalent rights in connection with vesting of restrictive stock. The rights accrued when and as dividends were paid on Regency's common stock and vested proportionately with the restricted stock. Each dividend equivalent is the equivalent of one share of Regency's common stock.
Remarks:
/s/Michael R. Herman Attorney-in-Fact05/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Regency Centers (REG) director C. Ronald Blankenship report on this Form 4?

He reported equity compensation vesting that increased his common stock holdings. Restricted stock and dividend equivalent rights converted into additional shares under Regency Centers’ Omnibus Incentive Plan, rather than any open‑market buying or selling activity.

How many Regency Centers (REG) shares did Blankenship acquire in this Form 4 filing?

He acquired 1,952 shares of common stock in total. This came from 1,875 restricted stock units vesting and 77 dividend equivalent rights settling into common shares on May 11, 2026, as part of his compensation.

What are dividend equivalent rights in the Regency Centers (REG) Form 4?

Dividend equivalent rights mirror cash dividends on underlying shares and accumulate as additional units. In this filing, 77 such rights vested and were settled into an equal number of Regency Centers common shares tied to the vested restricted stock award.

Did C. Ronald Blankenship sell any Regency Centers (REG) shares in this Form 4?

No, the filing shows no sales of common stock. All reported transactions are coded “M” for exercises or conversions of derivative securities, reflecting vesting of restricted stock and dividend equivalent rights, not open‑market selling activity.

How many Regency Centers (REG) shares does Blankenship own after these transactions?

After the reported vesting and conversions, he directly owns 114,679 shares of Regency Centers common stock. This figure reflects his updated direct ownership following the compensation-related transactions on May 11, 2026.

What plan governed the equity awards in this Regency Centers (REG) Form 4?

The awards were granted under Regency Centers’ Omnibus Incentive Plan. Footnotes state the restricted stock vested under this plan and dividend equivalent rights settled in connection with the same restricted stock vesting event.